Nanoparticle Processing in the Solid State Dramatically Increases the Cell Membrane Permeation of a Cholesterol-Lowering Drug, Probucol

被引:27
作者
Fukami, Toshiro [1 ,2 ]
Ishii, Tatsuya
Io, Takeshi
Suzuki, Naoto
Suzuki, Toyofumi
Yamamoto, Kazutoshi [3 ]
Xu, Jiadi [3 ]
Ramamoorthy, Ayyalusamy [1 ,3 ]
Tomono, Kazuo
机构
[1] Nihon Univ, Coll Pharm, Res Unit Pharmaceut, Chiba 2748555, Japan
[2] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
Cogrinding; drug delivery; nanoparticles; NMR spectroscopy; solid-state reactions; METHACRYLIC-ACID COPOLYMER; SOLUBLE DRUGS; PARTICLES; RISK; HYPERCHOLESTEROLEMIA; FORMULATION; MONOLAYERS; RATS; NMR;
D O I
10.1021/mp9000487
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
High cholesterol levels (or hypercholesterolemia) are linked with many diseases, particularly with the risk of coronary heart diseases. Probucol is commonly used to reduce cholesterol in blood. While the effectiveness of this drug highly depends on its solubility, unfortunately, it is nearly insoluble (solubility is 5 ng/mL in water). Therefore, it is essential to develop approaches to increase its solubility and bioavailability and to enhance the efficiency of the drug. Here we show that a new method increases the solubility of probucol in water and its ability to permeate cell membranes. This new method of processing the drug in a nanoparticle utilizes the grinding of PBC probucol together with sodium dodecylsulfate and methacrylic copolymer. Solid-state NMR experiments reveal the polymorphic state of probucol and the conversion of this drug from crystalline to the amorphous state, and determine its nearness to the copolymer due to the grinding process that enables the formation of nanoparticles.
引用
收藏
页码:1029 / 1035
页数:7
相关论文
共 29 条
[1]   Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia.: Effects on apolipoprotein AI-containing lipoprotein particles [J].
Adlouni, A ;
El Messal, M ;
Saïle, R ;
Parra, HJ ;
Fruchart, JC ;
Ghalim, N .
ATHEROSCLEROSIS, 2000, 152 (02) :433-440
[2]   How safe are very low LDL cholesterol levels? [J].
Baghdasarian, S. B. ;
Thompson, P. D. .
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (06) :306-307
[3]   Oral treatment with probucol in a pharmacological dose has no beneficial effects on mortality in chronic ischemic heart failure after large myocardial infarction in rats [J].
Betge, Stefan ;
Lutz, Katharina ;
Roskos, Martin ;
Figulla, Hans-Reiner .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 558 (1-3) :119-127
[4]   Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse [J].
Braun, A ;
Zhang, SW ;
Miettinen, HE ;
Ebrahim, S ;
Holm, TM ;
Vasile, E ;
Post, MJ ;
Yoerger, DM ;
Picard, MH ;
Krieger, JL ;
Andrews, NC ;
Simons, M ;
Krieger, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (12) :7283-7288
[5]   Influence of monocaprin on the permeability of a diacidic drug BTA-243 across Caco-2 cell monolayers and everted gut sacs [J].
Brown, JR ;
Collett, JH ;
Attwood, D ;
Ley, RW ;
Sims, EE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 245 (1-2) :133-142
[6]   The effect of crystal morphology and mill type on milling induced crystal disorder [J].
Chikhalia, V ;
Forbes, RT ;
Storey, RA ;
Ticehurst, M .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 27 (01) :19-26
[7]   Enhancement of water solubility of fullerene by cogrinding with mixture of cycloamyloses, novel cyclic α-1,4-glucans, via solid-solid mechanochemical reaction [J].
Fukami, T ;
Mugishima, A ;
Suzuki, T ;
Hidaka, S ;
Endo, T ;
Ueda, H ;
Tomono, K .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (08) :961-964
[8]   Versatility of three techniques for preparing ibuprofen-loaded methacrylic acid copolymer nanoparticles of controlled sizes [J].
Galindo-Rodríguez, S ;
Allémann, E ;
Doelker, E ;
Fessi, H .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2005, 15 (05) :347-354
[9]   Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability [J].
Gao, P ;
Rush, BD ;
Pfund, WP ;
Huang, TH ;
Bauer, JM ;
Morozowich, W ;
Kuo, MS ;
Hageman, MJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (12) :2386-2398
[10]   The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity [J].
Hanai, Jun-ichi ;
Cao, Peirang ;
Tanksale, Preeti ;
Imamura, Shintaro ;
Koshimizu, Eriko ;
Zhao, Jinghui ;
Kishi, Shuji ;
Yamashita, Michiaki ;
Phillips, Paul S. ;
Sukhatme, Vilkas P. ;
Lecker, Stewart H. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (12) :3940-3951